Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
GlaxoSmithKline and Vir Biotechnology have announced the European Medicines Agency (EMA) review of VIR-7831 (GSK4182136) for the early treatment of Covid-19.
Drug Delivery
-
16 Apr 2021
-
17 Mar 2021
AstraZeneca to deliver 500,000 more doses of AZD7442 to US
The UK’s Cambridge-based biopharma company AstraZeneca will be delivering 500,000 more doses of AZD7442 to the US after having modified an existing agreement with the US Government.
-
10 Feb 2021
USFDA approves EUA for bamlanivimab-etesevimab combo to treat Covid-19 patients
The U.S. Food and Drug Administration (FDA) has approved Emergency Use Authorization (EUA) for investigational bamlanivimab and etesevimab as a combination therapy for the treatment of mild to moderate Covid-19 patients.
-
26 Dec 2018
Researchers conduct study to identify common genetic architecture of PCOS
International PCOS Consortium has carried out a study to determine the common genetic architecture for different diagnostic criteria that are employed to describe polycystic ovary syndrome (PCOS).